{"title":"When Should Pediatric Inflammatory Bowel Disease Patients Be Allowed to Take Approved Therapies for Adults?","authors":"Michael D Kappelman","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":52498,"journal":{"name":"Gastroenterology and Hepatology","volume":"22 4","pages":"168-171"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13322308/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148370944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Role of Contrast-Enhanced Ultrasound in Hepatocellular Carcinoma Diagnosis.","authors":"Yuko Kono","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":52498,"journal":{"name":"Gastroenterology and Hepatology","volume":"22 4","pages":"150-152"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13322306/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148370860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Exploring the Disease Entity of MetALD.","authors":"Gary R Lichtenstein","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":52498,"journal":{"name":"Gastroenterology and Hepatology","volume":"22 5","pages":"215"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13334692/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148438833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Innovations in Endoscopic Submucosal Dissection Techniques and Technologies.","authors":"Mohammad Bilal","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":52498,"journal":{"name":"Gastroenterology and Hepatology","volume":"22 4","pages":"155-157"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13322333/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148370887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Innovations in Liver Transplant.","authors":"Marina Serper","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":52498,"journal":{"name":"Gastroenterology and Hepatology","volume":"22 4","pages":"161-163"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13322307/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148370918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Differences in Inflammatory Bowel Disease Across Ethnicities and Racial Groups.","authors":"Oriana M Damas","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":52498,"journal":{"name":"Gastroenterology and Hepatology","volume":"22 6","pages":"319-322"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13322324/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148370924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Elyse R Thakur, Kate Scarlata, Brennan Spiegel, David J Hass
{"title":"Beyond Medication: Integrative and Nutrition Therapies for Disorders of Gut-Brain Interaction.","authors":"Elyse R Thakur, Kate Scarlata, Brennan Spiegel, David J Hass","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Disorders of gut-brain interaction (DGBIs), such as irritable bowel syndrome and functional dyspepsia, affect a substantial portion of the global population. These disorders are best conceptualized through a biopsychosocial framework, reflecting the complex interplay and bidirectional communication among biological, psychological, and social factors. While conventional pharmaceutical treatments remain limited in efficacy and patient satisfaction, interest in integrative approaches to care continues to grow. However, despite the increasing use of integrative interventions for DGBIs, their therapeutic targets and underlying mechanisms remain poorly defined. This article aims to describe current and emerging integrative and nutrition-based interventions for DGBIs and evaluate their potential to complement conventional medicine by addressing a broader spectrum of biopsychosocial risk factors.</p>","PeriodicalId":52498,"journal":{"name":"Gastroenterology and Hepatology","volume":"22 4","pages":"177-187"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13322314/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148370915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dhruvi Shah, Jana Karam, Angelina Hao, Chrisandra Shufelt, Jami Kinnucan
{"title":"Impact of Menopause and Clinical Considerations in Patients With Inflammatory Bowel Disease.","authors":"Dhruvi Shah, Jana Karam, Angelina Hao, Chrisandra Shufelt, Jami Kinnucan","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Menopause is marked by a natural decline in estrogen and progesterone that alters gut barrier integrity, immune regulation, and systemic inflammation. In women with inflammatory bowel disease (IBD), this interplay may result in increased symptoms and worse clinical outcomes. Women with IBD face diagnostic delays, distinct disease phenotypes, higher rates of extraintestinal manifestations, and greater treatment burden. In menopausal women with IBD, specific guidance remains scarce. Beyond gut-specific effects, menopausal women are at an increased risk of osteoporosis, cardiovascular disease, and mood disorders. Lacking is a framework that promotes individualized, multidisciplinary care for menopausal women with IBD, focusing on the alterations in the immune system, gut microbiome, clinical presentations, multisystem risks, and therapeutic considerations. This article aims to synthesize the current evidence and research gaps around the impact of menopause in IBD, evaluate the safety and effectiveness of menopausal hormone therapy in this context, and propose a practical, patient-centered management framework for clinicians.</p>","PeriodicalId":52498,"journal":{"name":"Gastroenterology and Hepatology","volume":"22 4","pages":"196-204"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13334693/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148438858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"New Developments in the Treatment of Hepatitis B Virus Infection.","authors":"Sunny Sandhu, Paul Martin, Ira M Jacobson","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Chronic hepatitis B virus (HBV) infection remains a serious global public health concern and a leading cause of liver cirrhosis and hepatocellular carcinoma. Although currently available oral therapies can effectively suppress HBV DNA, there is no approved regimen that has shown to reliably achieve a functional cure. In recent years, various classes of novel therapy for HBV infection have undergone considerable research and advanced to clinical trials, targeting multiple stages of the viral life cycle and systemic immunomodulatory pathways. This article discusses the complex HBV life cycle and highlights emerging therapeutic advances on the horizon for HBV treatment.</p>","PeriodicalId":52498,"journal":{"name":"Gastroenterology and Hepatology","volume":"22 7","pages":"350-361"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13552428/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148914360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Raising the Bar on Risk Reduction in Post-ERCP Pancreatitis Prevention.","authors":"B Joseph Elmunzer","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":52498,"journal":{"name":"Gastroenterology and Hepatology","volume":"22 6","pages":"323-326"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13322328/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148370883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}